|
2024
|
Invention
|
Methods of using dichlorophenol hsd17b13 inhibitors. Described herein are HSD17B13 inhibitors and... |
|
2023
|
Invention
|
Dichlorophenol hsd17b13 inhibitors and uses thereof.
Described herein are HSD17B13 inhibitors an... |
|
|
Invention
|
Hsd17b13 inhibitors and uses thereof. Described herein are HSD17B13 inhibitors and pharmaceutical... |
|
|
Invention
|
Dichlorophenol hsd17b13 inhibitors and uses thereof. Described herein are HSD17B13 inhibitors and... |
|
|
Invention
|
Liver disease treatment and assessment using oxylipins. Provided are biomarker panels and methods... |
|
|
Invention
|
2-substituted thiazole hsd17b13 inhibitors and uses thereof. Described herein are selective HSD17... |
|
2022
|
Invention
|
Hydroxypyridine hsd17b13 inhibitors and uses thereof.
Described herein are hydroxypyridine HSD17... |
|
|
Invention
|
Thiazole/isothiazole hsd17b13 inhibitors and uses thereof.
Described herein are HSD17B13 inhibit... |
|
|
Invention
|
Thiazole/isothiazole hsd17b13 inhibitors and uses thereof. Described herein are HSD17B13 inhibito... |
|
|
Invention
|
Hydroxypyridine hsd17b13 inhibitors and uses thereof. Described herein are hydroxypyridine HSD17B... |
|
2021
|
Invention
|
Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver... |
|
|
Invention
|
Uses for hsd17b13 inhibitors. Described herein are HSD17B13 inhibitors and pharmaceutical composi... |
|
|
Invention
|
Plasma and tissue molecular markers of liver disease and utility for treatment. Provided are biom... |
|
|
Invention
|
Quinazolinone hsd17b13 inhibitors and uses thereof.
Described herein are HSD17B13 inhibitors and... |
|
|
Invention
|
Thiophene hsd17b13 inhibitors and uses thereof.
Described herein are HSD17B13 inhibitors and pha... |
|
|
Invention
|
Quinazolinone hsd17b13 inhibitors and uses thereof. Described herein are HSD17B13 inhibitors and ... |
|
|
Invention
|
Thiophene hsd17b13 inhibitors and uses thereof. Described herein are HSD17B13 inhibitors and phar... |
|
|
Invention
|
Hsd17b13 inhibitors and uses thereof.
Described herein are HSD17B13 inhibitors and pharmaceutica... |
|
|
Invention
|
Methods and compositions for treating drug induced steatohepatitis. Disclosed herein are methods ... |
|
|
Invention
|
Substrate selective hsd17b13 inhibitors and uses thereof. Described herein are substrate specific... |
